Results 151 to 160 of about 274,076 (393)

Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study

Cytometry Part B: Clinical Cytometry, EarlyView.
ABSTRACT Anticipating the evolution of septic patients with community‐acquired pneumonia (CAP) is challenging for front‐line physicians in the Emergency Department (ED). Prognosis depends mainly on early identification, antibiotics, organ support, but also immune status.
Thomas Lafon, Robin Jeannet, Thomas Daix, Guillaume Monneret, Jean Feuillard   +4 more
wiley   +1 more source

CLOZAPINE RECHALLENGE WITH LITHIUM AFTER DOUBLE INDUCED NEUTROPENIA: A CASE REPORT

Dialogues in Clinical Neuroscience & Mental Health, 2019
Clozapine is a second generation antipsychotic drug, which has been acknowledged as the gold standard for treating both positive and negative symptoms of treatment-resistant schizophrenic patients, despite its severe side effects, such as neutropenia ...
A. Kourti, K. Paschalidis, C-M. Platsa, D. Garnelis, I. Tsiamis, A. Karampas, P. Argitis   +6 more
doaj   +1 more source

Brief Report: Amyloidosis Associated with Cyclic Neutropenia in the Dog [PDF]

, 1968
N. F. Cheville
openalex   +1 more source

Reply to: Methotrexate toxicity and glucarpidase: A call for dose optimization. Koppen A, et al. Br J Clin Pharmacol. 2025;91(5):1289‐1292 doi:10.1002/bcp.70044

British Journal of Clinical Pharmacology, EarlyView.
Carmelo Rizzari, Stefan Schwartz
wiley   +1 more source

Combined Tumor Infiltrating Lymphocytes and PD‐L1 Status in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Objectives To determine if the assessment of CD8+ tumor‐infiltrating lymphocytes (TILs) adds prognostic information to the PD‐L1 combined positive score (CPS) in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Methods A retrospective case series was performed of 77 patients with R/M HNSCC between 2003 and 2019.
Catherine T. Haring, Joshua D. Smith, Sarah M. Dermody, Jonathan B. McHugh, William R. Perry, Collin Brummel, Matthew E. Spector, J. Chad Brenner, Paul L. Swiecicki   +8 more
wiley   +1 more source

Osteomyelitis: an unusual sequel to neutropenia. [PDF]

, 1967
L. R. I. Baker, M. C. Brain, J Miller, M. J. Raphael   +3 more
openalex   +1 more source

Prospective Registry Trial of Adjuvant High‐Dose Rate Brachytherapy in Unirradiated Head and Neck Cancer: 20‐Year Data

Head &Neck, EarlyView.
ABSTRACT Background and Purpose Full‐dose postoperative external beam radiation therapy (EBRT)/chemoradiation is the standard of care in patients with resected, unirradiated head and neck cancer (HNC). This study aims to determine the long‐term results of adjuvant high‐dose rate (HDR) brachytherapy ± intermediate‐dose postoperative external beam ...
Alejandro García‐Consuegra, Marta Gimeno‐Morales, Mauricio Cambeiro, José María López‐Picazo, Juan Alcalde, Luis I Ramos, Luca Tagliaferri, José Luis Guinot, Francesco Bussu, Marta Moreno‐Jiménez, Rafael Martinez‐Monge   +10 more
wiley   +1 more source

Cyclic Neutropenia: The Relationship Between Urine Granulocyte Colony Stimulating Activity and Neutrophil Count [PDF]

, 1973
Aroop Mangalik, William A. Robinson
openalex   +1 more source

Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum‐Based Therapy

Head &Neck, EarlyView.
ABSTRACT Background Adenoid cystic carcinoma (ACC) is the second most common and treatment‐resistant salivary gland carcinoma (SGC). Although platinum‐based therapies are effective, the efficacy of eribulin, a microtubule inhibitor with an 18% response rate in a Phase II trial involving recurrent/metastatic SGC, in patients with advanced ACC after ...
Tomomi Sanomachi, Tatsunori Shimoi, Yuki Kojima, Hideaki Takahashi, Motoko Arakaki, Asuka Kawachi, Hitomi Sumiyoshi Okuma, Mai Hoshino, Munehiro Ito, Ayumi Saito, Shosuke Kita, Aiko Maejima, Tadaaki Nishikawa, Kazuki Sudo, Taisuke Mori, Yasuhiro Fujiwara, Kan Yonemori   +16 more
wiley   +1 more source

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

Head &Neck, EarlyView.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon, Cyril Abdeddaim, DucTrung Nguyen, Patrice Gallet, Didier Peiffert, Aurélien Lambert, Lionnel Geoffrois   +6 more
wiley   +1 more source